Initial pharmacotherapy in a population of veterans with Parkinson disease

Kari Swarztrauber, Caroline Koudelka, Matthew Brodsky

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

The authors analyzed patient and prescribing provider characteristics for 530 veterans identified from VA pharmacy records with Parkinson disease (PD) and initial pharmacotherapy. Neurologists prescribed 29% of initial therapy. While a patient being younger and seeing a movement disorder specialist predicted receiving dopamine agonists, only 20% of patients younger than age 65 years received dopamine agonists. Initial pharmacotherapy is strongly influenced by the provider's specialty but mostly initiated by providers without PD expertise.

Original languageEnglish (US)
Pages (from-to)1425-1426
Number of pages2
JournalNeurology
Volume66
Issue number9
DOIs
StatePublished - May 2006

Fingerprint

Veterans
Parkinson Disease
Dopamine Agonists
Drug Therapy
Population
Movement Disorders
Therapeutics

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Initial pharmacotherapy in a population of veterans with Parkinson disease. / Swarztrauber, Kari; Koudelka, Caroline; Brodsky, Matthew.

In: Neurology, Vol. 66, No. 9, 05.2006, p. 1425-1426.

Research output: Contribution to journalArticle

Swarztrauber, Kari ; Koudelka, Caroline ; Brodsky, Matthew. / Initial pharmacotherapy in a population of veterans with Parkinson disease. In: Neurology. 2006 ; Vol. 66, No. 9. pp. 1425-1426.
@article{5f6e4014ae40478e8d8a74396ff7f881,
title = "Initial pharmacotherapy in a population of veterans with Parkinson disease",
abstract = "The authors analyzed patient and prescribing provider characteristics for 530 veterans identified from VA pharmacy records with Parkinson disease (PD) and initial pharmacotherapy. Neurologists prescribed 29{\%} of initial therapy. While a patient being younger and seeing a movement disorder specialist predicted receiving dopamine agonists, only 20{\%} of patients younger than age 65 years received dopamine agonists. Initial pharmacotherapy is strongly influenced by the provider's specialty but mostly initiated by providers without PD expertise.",
author = "Kari Swarztrauber and Caroline Koudelka and Matthew Brodsky",
year = "2006",
month = "5",
doi = "10.1212/01.wnl.0000210433.49727.40",
language = "English (US)",
volume = "66",
pages = "1425--1426",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "9",

}

TY - JOUR

T1 - Initial pharmacotherapy in a population of veterans with Parkinson disease

AU - Swarztrauber, Kari

AU - Koudelka, Caroline

AU - Brodsky, Matthew

PY - 2006/5

Y1 - 2006/5

N2 - The authors analyzed patient and prescribing provider characteristics for 530 veterans identified from VA pharmacy records with Parkinson disease (PD) and initial pharmacotherapy. Neurologists prescribed 29% of initial therapy. While a patient being younger and seeing a movement disorder specialist predicted receiving dopamine agonists, only 20% of patients younger than age 65 years received dopamine agonists. Initial pharmacotherapy is strongly influenced by the provider's specialty but mostly initiated by providers without PD expertise.

AB - The authors analyzed patient and prescribing provider characteristics for 530 veterans identified from VA pharmacy records with Parkinson disease (PD) and initial pharmacotherapy. Neurologists prescribed 29% of initial therapy. While a patient being younger and seeing a movement disorder specialist predicted receiving dopamine agonists, only 20% of patients younger than age 65 years received dopamine agonists. Initial pharmacotherapy is strongly influenced by the provider's specialty but mostly initiated by providers without PD expertise.

UR - http://www.scopus.com/inward/record.url?scp=33646693452&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33646693452&partnerID=8YFLogxK

U2 - 10.1212/01.wnl.0000210433.49727.40

DO - 10.1212/01.wnl.0000210433.49727.40

M3 - Article

VL - 66

SP - 1425

EP - 1426

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 9

ER -